Need to improve easy access to HIV pre-exposure prophylaxis PrEP
Tag: AIDS/HIV
Researchers identify potential therapy for liver disease in people living with HIV
BOSTON – A team of researchers at Massachusetts General Hospital (MGH) led by Steven Grinspoon, MD, has identified a novel therapeutic strategy to significantly improve a form of liver disease that affects many people living with human immunodeficiency virus (HIV),…
Drug reverses signs of liver disease in people living with HIV
Tesamorelin prevented progression to liver fibrosis in NIH study
CUNY SPH awarded 2 grants to support public health programs on CUNY campuses
New York – The CUNY Graduate School of Public Health and Health Policy (CUNY SPH) Foundation has announced two new grants to launch and expand programs that focus on improving the health and wellbeing of CUNY students. The Levitt Foundation…
NYDOE AIDS Institute awards $1M grant to SUNY Downstate HEAT program
Funding to support essential health services for transgender youth
First video of viruses assembling
Research offers rare view into the formation of viruses
Tracking the HI virus
Researchers make visible, how AIDS pathogens multiply in the body
Study demonstrates antibody responses within 6 weeks of initial vaccination
SEATTLE, OCTOBER 01, 2019 – An early phase study was conducted in the U.S. in which different combinations of DNA (DNA-HIV-PT123) and protein (AIDSVAX® B/E) vaccines were administered in four randomized treatment groups (T1, T2, T3, T4), to determine which…
The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
Low rates of successful initiation of antiretroviral treatment among 15-19 year olds highlights urgent need to improve services for adolescents
Collaboration may improve access to HIV testing, primary care
ANN ARBOR–Getting better access to testing and proper primary care for individuals vulnerable to HIV could be as simple as a telephone call or email among health providers. Social workers, health educators and other health providers who receive on-the-job training…
AIDS and Cancer Specimen Resource renewed with $22 Million grant
The AIDS and Cancer Specimen Resource has been renewed for 5 years
New fungus-derived antibiotic: relief in sight for immunocompromised people
Scientists derive a new compound from eushearilide, which can potentially take on lethal fungal and bacterial infections
Fullerene compounds knock out virus infections
Scientists from the Skoltech Center for Energy Science and Technology and the Institute of Problems of Chemical Physics of RAS in collaboration with researchers from four other Russian and foreign research centers have discovered a new reaction that helps obtain…
A promising HIV vaccine shows signs of cross-protective benefits
One of the most successful candidate HIV vaccines to date – initially tested in Thailand, where it had modest effects – showed surprisingly strong efficacy when evaluated in a South African cohort, where a different strain of HIV is known…
Cross clade immune responses found in South Africa from the RV144/Thai HIV vaccine regimen
SEATTLE, SEPTEMBER 18, 2019 – The results of the study called HVTN 097, titled “Immune correlates of the Thai RV144 vaccine regimen in South Africa” and led by Dr. Glenda Gray, Co-Principal Investigator of the HIV Vaccine Trials Network (HVTN),…
Knotty problem of cell reprogramming solved, USC scientists report
The researchers found a way to repurpose cells more reliably than current methods by untangling DNA,
Australian immunology pioneer Jacques Miller wins Lasker Award
Emeritus Professor Jacques Miller AC from Melbourne’s Walter and Eliza Hall Institute has won a Lasker Award, one of the highest international honours in medical research. Professor Miller was joint recipient of the 2019 Albert Lasker Basic Medical Research Award…
NIH bolsters funding for HIV implementation research in high-burden US areas
Community-based research sets stage for implementation of HHS initiative
UC San Diego receives funding from Ending the HIV Epidemic Initiative
As a result of the “Ending the HIV Epidemic: A Plan for America” initiative, which emerged from President Donald J. Trump’s vow during his 2019 State of Union Address to end the HIV epidemic within 10 years, the San Diego…
Texas Biomed hires new primate center researcher
Professor studies the impact of cannabinoids on HIV infection and inflammation
PrEParing family planning clinics in Kenya to prevent new HIV infections
In sub-Saharan Africa, many young women and adolescent girls are at high risk of HIV infection. In a new research paper published in the open access journal PLOS Medicine, Kenneth Mugwanya and co-authors report on a study aiming to investigate…
New sequencing study provides insight into HIV vaccine protection
RNA-sequencing reveals B cell gene signature associated with protective efficacy of SIV and HIV vacc
Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population. A new study looked into the importance of…
Repeated semen exposure promotes host resistance to infection in preclinical HIV model
Changes in systemic and local tissue responses reduce susceptibility but do not block infection
Age-related illness risk for people living with HIV
Study finds increased incidence of heart disease, COPD and bone fractures
New BioIVT research examines potential link between HIV integrase inhibitor drugs and neural tube de
This research, which investigates the risk of drug-induced folate deficiency with HIV integrase inhi
Landmark NIH funding extended for CUNY’s bold HIV/AIDS prevention research initiative
The National Institutes of Health (NIH) has extended funding through 2022 for Together 5000 (T5K), a nationwide HIV prevention study led by Dr. Christian Grov of the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the…
NIH awards $2.7 million grant to UTEP professor to study AIDS-associated fungal meningitis
The National Institutes of Health recently awarded a $2.7 million grant to Luis R. Martinez, Ph.D., associate professor of biological sciences at The University of Texas at El Paso, to study a potentially life-threatening fungus and suggest possible treatments. Martinez…